Literature DB >> 9588866

Surface-modified amikacin-liposomes: organ distribution and interaction with plasma proteins.

W E Bucke1, S Leitzke, J E Diederichs, K Borner, H Hahn, S Ehlers, R H Müller.   

Abstract

Amikacin-loaded liposomes were produced and surface-modified by adsorption of PEG 4000, Tween 80, poloxamer 407 and gelatin. The organ distribution was studied in mice by analysing the amikacin content in liver, spleen, lung, kidneys and serum. Highest serum levels were obtained with the PEG- and Tween 80 modified liposomes (at 2 hours p.inj.). Modification of the liposomes with gelatin as opsonization promoting agent distinctly increased the amikacin concentration in the liver from 36 to 66 mg/kg. Highest spleen concentrations were observed with non-modified and poloxamer 407 liposomes (242 mg/kg and 248 mg/kg, respectively). The data suggest that modification by a simple adsorption process is sufficient to effectively alter the organ distribution. The liposomes differing in organ distribution exhibited also different plasma protein adsorption patterns, up to 115 spots were detected by 2-D PAGE. Hydrophilic albumin was present in a conc. of appr. 80% on liposomes modified with ethoxylated compounds. On the gelatin liposomes, 14% of alpha-2-Macroglobulin were adsorbed which is a protein typically found on particles rapidly cleared by the RES. IgM, Apo A-I, Apo C-II and alpha-1-Antitrypsin were other detected proteins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9588866     DOI: 10.3109/10611869808995863

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  4 in total

Review 1.  Aminoglycoside modifying enzymes.

Authors:  Maria S Ramirez; Marcelo E Tolmasky
Journal:  Drug Resist Updat       Date:  2010-09-15       Impact factor: 18.500

2.  Novel anion liposome-encapsulated antisense oligonucleotide restores susceptibility of methicillin-resistant Staphylococcus aureus and rescues mice from lethal sepsis by targeting mecA.

Authors:  Jingru Meng; Hui Wang; Zheng Hou; Tao Chen; Jingguo Fu; Xue Ma; Gonghao He; Xiaoyan Xue; Min Jia; Xiaoxing Luo
Journal:  Antimicrob Agents Chemother       Date:  2009-05-11       Impact factor: 5.191

3.  Stealth and Cationic Nanoliposomes as Drug Delivery Systems to Increase Andrographolide BBB Permeability.

Authors:  Vieri Piazzini; Elisa Landucci; Giulia Graverini; Domenico E Pellegrini-Giampietro; Anna Rita Bilia; Maria Camilla Bergonzi
Journal:  Pharmaceutics       Date:  2018-08-13       Impact factor: 6.321

Review 4.  Immunological and Toxicological Considerations for the Design of Liposomes.

Authors:  Collin T Inglut; Aaron J Sorrin; Thilinie Kuruppu; Shruti Vig; Julia Cicalo; Haroon Ahmad; Huang-Chiao Huang
Journal:  Nanomaterials (Basel)       Date:  2020-01-22       Impact factor: 5.076

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.